RG
Redmile Group’s Kymera Therapeutics KYMR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.1M | Sell |
803,289
-180,124
| -18% | -$7.86M | 3.73% | 12 |
|
|
2025
Q1 | $26.9M | Sell |
983,413
-117,019
| -11% | -$3.2M | 2.54% | 13 |
|
|
2024
Q4 | $44.3M | Sell |
1,100,432
-292,824
| -21% | -$11.8M | 3.09% | 10 |
|
|
2024
Q3 | $65.9M | Sell |
1,393,256
-186,019
| -12% | -$8.8M | 3.88% | 5 |
|
|
2024
Q2 | $47.1M | Sell |
1,579,275
-154,814
| -9% | -$4.62M | 2.85% | 10 |
|
|
2024
Q1 | $69.7M | Sell |
1,734,089
-89,867
| -5% | -$3.61M | 2.56% | 8 |
|
|
2023
Q4 | $46.4M | Sell |
1,823,956
-44,551
| -2% | -$1.13M | 1.66% | 17 |
|
|
2023
Q3 | $26M | Hold |
1,868,507
| – | – | 1.24% | 26 |
|
|
2023
Q2 | $43M | Sell |
1,868,507
-542,262
| -22% | -$12.5M | 1.65% | 17 |
|
|
2023
Q1 | $71.4M | Sell |
2,410,769
-263,068
| -10% | -$7.79M | 3.1% | 8 |
|
|
2022
Q4 | $66.7M | Sell |
2,673,837
-202,800
| -7% | -$5.06M | 2.73% | 11 |
|
|
2022
Q3 | $62.6M | Buy |
2,876,637
+269,507
| +10% | +$5.87M | 2.43% | 12 |
|
|
2022
Q2 | $51.3M | Sell |
2,607,130
-7,900
| -0.3% | -$156K | 1.96% | 15 |
|
|
2022
Q1 | $111M | Buy |
2,615,030
+27,300
| +1% | +$1.16M | 3.45% | 6 |
|
|
2021
Q4 | $164M | Sell |
2,587,730
-205,978
| -7% | -$13.1M | 3.74% | 6 |
|
|
2021
Q3 | $164M | Buy |
2,793,708
+262,200
| +10% | +$15.4M | 2.86% | 11 |
|
|
2021
Q2 | $123M | Sell |
2,531,508
-71,631
| -3% | -$3.47M | 1.82% | 16 |
|
|
2021
Q1 | $101M | Sell |
2,603,139
-117,350
| -4% | -$4.56M | 1.42% | 21 |
|
|
2020
Q4 | $169M | Sell |
2,720,489
-12,171
| -0.4% | -$755K | 2.04% | 13 |
|
|
2020
Q3 | $88.3M | Buy |
+2,732,660
| New | +$88.3M | 1.62% | 17 |
|